openPR Logo
Press release

Global RNAi Therapeutics Market Is Projected To Witness Vigorous Expansion By 2026 | Quark, F. Hoffmann-La Roche Ltd., Rexahn Pharmaceuticals, Inc., Silence Therapeutics

08-12-2020 02:56 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Global RNAi Therapeutics Market

Global RNAi Therapeutics Market

Data Bridge Market Research has recently added a concise research on the Global RNAi Therapeutics Market to depict valuable insights related to significant market trends driving the industry. The report features analysis based on key opportunities and challenges confronted by market leaders while highlighting their competitive setting and corporate strategies for the estimated timeline. The development plans, market risks, opportunities and development threats are explained in detail. The CAGR value, technological development, new product launches and Industry competitive structure is elaborated. As per study key players of this market are Quark, F. Hoffmann-La Roche Ltd., Rexahn Pharmaceuticals, Inc., Silence Therapeutics, Arbutus Biopharma, Benitec Biopharma, GlaxoSmithKline plc, OLIX PHARMACEUTICALS, INC., Sanofi, Alnylam Pharmaceuticals, Inc and more.

Market Analysis and Insights of Global RNAi Therapeutics Market

RNAi therapeutics market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 571.5 million by 2027 growing at a CAGR of 6.4% in the above-mentioned forecast period. Increasing usage of RNAi therapeutics for the treatment of neurodegenerative disorders is expected to create new opportunity for the market.

Get Sample Report + All Related Graphs & Charts (with COVID 19 Analysis) @

Increasing cases of chronic diseases such as cancer, cardiovascular diseases and other is expected to enhance the market growth. Some of the other factors such as increasing approvals for RNAi therapeutics, development in the healthcare industry, rising R&D investment, and increasing collaborations among pharmaceutical companies will further drive the RNAi therapeutics market in the forecast period of 2020 to 2027.

Complexity associated with the delivery of RNAi therapeutics and off-target effects is expected to hamper the market growth in the mentioned forecast period.

Competitive Landscape and RNAi Therapeutics Market Share Analysis

RNAi therapeutics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to RNAi therapeutics market.

The major players covered in the RNAi therapeutics market report are Quark, F. Hoffmann-La Roche Ltd., Rexahn Pharmaceuticals, Inc., Silence Therapeutics, Arbutus Biopharma, Benitec Biopharma, GlaxoSmithKline plc, OLIX PHARMACEUTICALS, INC., Sanofi, Alnylam Pharmaceuticals, Inc., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Grab Your Report at an Impressive 30% Discount! Please click Here @

This RNAi therapeutics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research RNAi therapeutics market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global RNAi Therapeutics Market Scope and Market Size

RNAi therapeutics market is segmented of the basis of molecule type, application, route of administration and end- user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

On the basis of molecule type, the RNAi therapeutics market is segmented into small interfering RNAS and microrna.
Based on application, the RNAi therapeutics market is segmented into genetic disorder, oncology, neurodegenerative disorder, cardiovascular disorder, respiratory disorder, infectious disease, renal disease and other.
The route of administration segment of the RNAi therapeutics market is divided into intradermal injections, pulmonary delivery, intravenous injections, intraperitoneal injections and others.
On the basis of end- users, the RNAi therapeutics market is divided into diagnostic laboratories, research & academic laboratories and hospitals.

RNAi Therapeutics Market Country Level Analysis

RNAi therapeutics market is analysed and market size insights and trends are provided by c molecule type, application, route of administration and end- user as referenced above.

The countries covered in the RNAi therapeutics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

The country section of the RNAi therapeutics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

For More Insights Get FREE Detailed TOC @

Healthcare Infrastructure growth Installed base and New Technology Penetration

RNAi therapeutics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for RNAi therapeutics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the RNAi therapeutics market. The data is available for historic period 2010 to 2018.

Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.


Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email @

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global RNAi Therapeutics Market Is Projected To Witness Vigorous Expansion By 2026 | Quark, F. Hoffmann-La Roche Ltd., Rexahn Pharmaceuticals, Inc., Silence Therapeutics here

News-ID: 2110787 • Views: 417

More Releases from Data Bridge Market Research

Global Electrophoresis Reagents Market Share Size, Statistics, Demand, Revenue, …
Global Electrophoresis Reagents Market is estimated to rise from its initial estimated value of USD 0.94 billion in 2018 to an estimated value of USD 1.44 billion by 2026, registering a CAGR of 5.5% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing levels of chronic diseases globally. The report gives inside and industry Outlook on Electrophoresis Reagents market. It helps in
Global Image-Guided Radiation Therapy Market Growth, Overview, Driver, Restraint …
Global Image-Guided Radiation Therapy Market describes complete industry Outlook with in-depth analysis. This report also Includes the complete analysis of each segment in terms of opportunity, market attractiveness index and growth rate, top players and new comers in industry, competitive landscape, sales, price, revenue, gross margin, market share, market risks, opportunities, market barriers, and challenges.key statistics on the market status.which give the clear idea about the product differentiation and
Global Anesthesia Monitoring Market Potential Growth, Share, Demand And Analysis … added a new study on Global Anesthesia Monitoring Market Research Review 2018 that has been just made available providing an extensive knowledge and perceptions of the industry. In order to build a through future prospect for the Anesthesia Monitoring Market, the current and historical data has been gathered, classified and analyzed. Major industry experts and analysts examining the Anesthesia Monitoring Market worldwide were interviewed to obtain the data validating
Global Meditation Market 2020 Recent Development, Covid-19 Effect Analysis by To …
Meditation market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 9.0 billion by 2027 growing at a CAGR of 10.40% in the above-mentioned forecast period. The growing awareness amongst the individual and world population about the hidden power of meditation and its unconventional outcomes for the health benefits to lead a healthy life

All 5 Releases

More Releases for RNAi

Top Factors Driving the RNAi for Therapeutic Market
The qualitative research study conducted by HTF MI titled “Global RNAi for Therapeutic Market Size, Status and Forecast 2025” provides primary Data, surveys, Scope of the Product and vendor briefings. The market dynamic forces have been determined after conducting a detailed study of the Global RNAi for Therapeutic market. The study provides forecasts for RNAi for Therapeutic investments till 2022. RNA interference (RNAi) is a biological process in which RNA
RNAI Technology Market - Comprehensive Evaluation of Market By 2017
Transparency Market Research’s report on the Ribonucleic Acid Interference (RNAi) technologies market offers an analytical snapshot of this highly dynamic market within the pharmaceutical industry. This report provides an overview of the global RNAi technologies scenario, before detailing each critical segment-based on type, application, and products-within this market. As well as estimating market value of the RNAi technologies market in USD million, the report provides accurate market forecasts for market
Antisense and RNAi Therapeutics Market - Competitive Dynamics & Global Outlook 2 …
Global Antisense and RNAi Therapeutics Market: Overview The rising incidence of coronary artery diseases, cardiac ailments, and neurodegenerative and infectious diseases has led to the demand for antisense and RNai therapeutics. The market exhibits a strong pipeline of product and is looking forward to introduce several advancements in the RNAi drug delivery technology. These factors will act as high growth rendering drivers in the coming years. The global antisense and RNAi therapeutics
Agrow: RNAi
ReportsWorldwide has announced the addition of a new report title Agrow: RNAi to its growing collection of premium market research reports. Employed as a research tool in entomology and as a means of crop protection and pest control, RNA interference (RNAi) technology is a natural process used to ‘silence’ genes – a way of reducing or switching off the activity (or expression) of individual genes. With a major drive to tackle resistance
Global RNAi Drug Pipeline Analysis
“Global RNAi Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drugs being developed based upon RNAi technology. Research report covers all the ongoing drugs being developed in various development phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. Insight for each drug profile in
Global RNA Interference (RNAi) Therapy Market Outlook 2018
The popularity of RNAi technology has been increasing in recent times as is has become a major component of basic research, and in drug discovery. Over the years this technology has become an integral part of the process of determining the functions of gene, in analyzing pathways, and in the validation of the target both in academia and in industry. Since discovery, RNA interference is considered to be a turning